Source Data Verification (SDV) is a key component of clinical trial monitoring. It ensures that data entered into case report forms (CRFs) or electronic data capture (EDC) systems accurately reflect the source documents maintained at the clinical site. This tutorial provides a step-by-step guide for Clinical Research Associates (CRAs) and site staff to perform SDV efficiently, in alignment with regulatory and sponsor expectations.

What Is Source Data Verification (SDV)?

SDV is the process of comparing data recorded in the trial database to the original source data — such as patient charts, lab reports, or signed informed consent forms. As per USFDA and EMA guidance, SDV is a critical activity that supports the integrity, reliability, and credibility of clinical trial data.

Types of Source Documents in Clinical Trials

• Hospital medical records (paper or electronic)
• Clinic progress notes
• Signed informed consent forms (ICFs)
• Laboratory test reports
• Imaging reports (e.g., CT, MRI)
• Subject diaries and questionnaires
• Investigational product (IP) accountability records

When Is SDV Performed?

SDV typically occurs during Routine Monitoring Visits (RMVs), Interim Monitoring Visits, or Close-out Visits. It is guided by the monitoring plan, protocol-specific requirements, and risk-based monitoring strategies. Sites handling high-risk trials or critical data points (e.g., primary endpoints or safety data) undergo more frequent SDV.

Step-by-Step SDV Process for CRAs

Step 1: Review Pre-Visit SDV List

• Download the SDV checklist or plan from the CTMS
• Focus on subject visits flagged by the sponsor (e.g., first patients, SAE cases)
• Review pending data entry in EDC and missing forms

Step 2: Verify Informed Consent

• Ensure subject signed the latest IRB-approved ICF version
• Check date/time against study procedures (must be signed before any procedure)
• Confirm witness or translator signatures if applicable

Step 3: Compare EDC Entries with Source

• Verify subject demographics, inclusion/exclusion criteria
• Cross-check vital signs, labs, and adverse events
• Ensure IP administration dates match dispensing logs
• Confirm visit dates align with subject calendars and protocol schedule

Step 4: Document Discrepancies

• Flag any discrepancies in SDV notes or CRA worksheets
• Query unresolved differences in EDC and note justification
• Discuss with site staff and request updates or clarifications

Step 5: Sign Off SDV Completion

Once the verification is complete for a visit, the CRA should:

• Mark SDV status as complete in EDC (if system allows)
• Update CTMS visit report with SDV summary
• Note any findings in the Monitoring Visit Report (MVR)

Difference Between SDV and SDR (Source Data Review)

While SDV focuses on the exact data match between CRFs/EDC and source, Source Data Review (SDR) involves a broader assessment of documentation completeness, protocol adherence, and overall data quality. For example, checking whether a lab result was reviewed by the PI is part of SDR, not SDV.

Best Practices for Efficient SDV

• Organize source files by subject and visit
• Highlight sections to be verified using color-coded tabs
• Use digital source documents when permitted, following 21 CFR Part 11
• Maintain SDV logs to track pending or partial verifications
• Train site coordinators in SDV preparation using SOP templates

How Sponsors Use SDV Metrics

Sponsors analyze SDV completion rates, error trends, and CRA visit timelines to monitor trial quality. A sudden rise in discrepancies may prompt closer scrutiny or targeted re-training. Sponsors may also compare SDV rates with quality indicators from Stability Studies or risk-based monitoring platforms.

Regulatory Expectations for SDV

Regulators expect documented evidence of SDV activity. During inspections, agencies like the CDSCO or Health Canada may request:

• Signed CRA SDV checklists
• Monitoring Visit Reports with SDV coverage summaries
• Follow-up documentation of discrepancies

Conclusion

Source Data Verification is a cornerstone of clinical trial quality. By following structured steps and best practices, CRAs and site staff can ensure data consistency, reduce regulatory risk, and build confidence in the trial results. Effective SDV not only improves data reliability but also demonstrates a strong compliance culture, essential for successful trial completion and future audits.

In clinical trial monitoring, understanding the distinction between Source Data Verification (SDV) and Source Data Review (SDR) is essential for ensuring regulatory compliance and data integrity. While both processes deal with reviewing data at the site level, their goals, scope, and execution differ significantly. This tutorial provides clarity on SDV vs SDR and offers practical guidance for Clinical Research Associates (CRAs) and site teams.

Defining SDV and SDR

What is Source Data Verification (SDV)?

SDV is the act of comparing data entered in the case report forms (CRFs) or electronic data capture (EDC) systems to the original source documents. The goal is to ensure that the data recorded in the system matches exactly with the source, such as medical records, lab results, or signed informed consent forms.

What is Source Data Review (SDR)?

SDR is a broader quality control process in which the CRA reviews the source data to evaluate the accuracy, completeness, and protocol compliance of the documentation. SDR includes assessing how data are documented, whether protocol requirements are followed, and if the documentation supports the clinical narrative.

Key Differences Between SDV and SDR

When Should You Perform SDV vs SDR?

According to USFDA and EMA guidance on risk-based monitoring, SDV is performed on critical data points such as primary endpoints and serious adverse events (SAEs). SDR is often used to verify overall compliance, protocol deviations, and source completeness. Sponsors may define these requirements in the Monitoring Plan and risk assessments.

Examples of SDV and SDR Activities

SDV Examples:

• Confirming that systolic BP recorded in EDC matches the value in the subject chart
• Matching lab dates and values between the lab printout and the CRF
• Checking subject initials and dates on informed consent forms

SDR Examples:

• Ensuring the PI has reviewed lab abnormalities as per protocol
• Verifying that the AE narrative aligns with reported dates and outcomes
• Evaluating whether dosing logs reflect protocol-specified windows

CRA Responsibilities in SDV and SDR

During site visits, CRAs must allocate time for both SDV and SDR:

• SDV: Check data integrity across CRFs and source files
• SDR: Review protocol adherence and documentation standards
• Documentation: Clearly distinguish between SDV and SDR observations in the Monitoring Visit Report (MVR)

How CTMS Systems Support SDV and SDR

Modern Clinical Trial Management Systems (CTMS) allow for tracking SDV progress by subject and visit. SDR notes can also be logged, particularly when the CRA observes training needs, procedural non-compliance, or inconsistencies in documentation. Systems like EDC and CTMS should support flagging critical data that requires both SDV and SDR actions.

Best Practices for CRA Monitoring Teams

• Plan SDV and SDR activities according to subject visit timelines and data criticality
• Use checklists from Pharma SOP templates to avoid missing key areas
• Use standardized terminology in reports to describe findings
• Ensure your site staff are trained in maintaining quality source documentation, not just data transcription

How Regulators View SDV and SDR

During audits or inspections, agencies like CDSCO or Stability Studies evaluators may request to see CRA notes detailing both SDV accuracy and SDR completeness. A lack of thorough SDR can be flagged as a documentation gap or oversight in site supervision.

Conclusion

While SDV and SDR are often mentioned together, they serve distinct purposes. SDV verifies the correctness of recorded data, while SDR ensures that the story behind the data is complete and compliant. By mastering both processes, CRAs can elevate the quality of monitoring and ensure that clinical trials pass both sponsor reviews and regulatory inspections with confidence.

Standardizing Source Data Verification (SDV) is essential for ensuring consistent monitoring across sites and trials. Well-crafted SDV plan templates and SOPs guide Clinical Research Associates (CRAs) in executing and documenting SDV activities in alignment with regulatory expectations. In this tutorial, we’ll walk through the structure, content, and implementation of effective SDV documentation tools.

Why SDV Plans and SOPs Are Important

Without standardized procedures, CRAs may perform SDV inconsistently, leading to audit risks, missed data discrepancies, or non-compliance. Regulators such as USFDA and CDSCO expect sponsors to document how data is verified and to have procedures that ensure subject safety and data integrity.

Components of a Strong SDV Plan Template

An SDV plan is typically part of the overall Monitoring Plan but can also exist as a standalone document. Key components include:

1. Objectives and Scope

• Define what SDV is and its purpose in the context of the specific study
• Clarify whether full or risk-based SDV is applied

2. Roles and Responsibilities

• Outline the responsibilities of CRAs, site staff, and data managers
• Include communication and escalation workflows

3. Data Fields and Frequency

• Specify which fields (e.g., informed consent, AEs, primary endpoints) require 100% SDV
• Set frequency per subject visit (e.g., screening, dosing, follow-up)

4. Documentation and Tracking

• Provide templates for SDV checklists and CRF/EDC audit trails
• Reference tools like CTMS for tracking SDV progress

5. Risk Triggers

• Include escalation protocols if discrepancies or data quality issues arise
• Define site re-training or corrective action procedures

Creating an SDV SOP: What to Include

An SOP should provide operational guidance for CRAs and quality personnel. A recommended structure includes:

Section 1: Purpose

Explain why the SOP exists and how it ensures consistency in SDV execution.

Section 2: Scope

State whether the SOP applies to all studies or only specific types (e.g., pivotal, Phase 3 trials).

Section 3: Definitions

• SDV
• Source Documents
• EDC
• Critical Data

Section 4: Procedure

1. Pre-Visit Planning: Retrieve the SDV plan and subject-specific CRFs
2. Verification: Match data from source documents to the EDC
3. Discrepancy Handling: Record, query, and resolve mismatches
4. Documentation: Complete SDV logs and update monitoring reports

Section 5: Responsibilities

• CRA: Conducts SDV and documents findings
• Site Staff: Provides access to source data and implements corrections
• QA Manager: Reviews SOP adherence during audits

Section 6: References

• EMA GCP Guidelines
• Pharma SOP templates
• Stability Studies practices on source documentation

Using Templates Effectively

Ready-made templates allow for quick customization per protocol. Elements to include:

• Study-specific SDV checklist (screening, baseline, follow-up)
• Source data log
• Subject visit tracker with SDV columns
• Deviation and issue tracking sheet

Best Practices for Maintaining SDV SOPs

• Review SOPs annually or after each trial phase
• Train CRAs using mock SDV visits and SOP walkthroughs
• Maintain version control and change history
• Include SDV audit preparedness steps in SOP annexures

Common Pitfalls to Avoid

• Using outdated templates that don’t reflect current protocol
• Neglecting SDR documentation where applicable
• Failing to align SDV plan with Monitoring Plan or Data Management Plan

Conclusion

Well-defined SDV plan templates and SOPs are cornerstones of high-quality clinical monitoring. They not only improve operational consistency but also demonstrate compliance during audits. For CRAs, QA professionals, and sponsors, investing time in designing practical, risk-based, and regulatory-aligned SDV documentation ensures accuracy, efficiency, and inspection readiness.

Source Data Verification (SDV) is a core function of clinical monitoring. However, even perfectly executed SDV can lose its value if not appropriately documented in the Monitoring Visit Report (MVR). Regulatory authorities such as the USFDA and CDSCO emphasize that proper documentation of SDV activities is essential to ensure data integrity, protocol compliance, and audit readiness. This tutorial explains how CRAs should capture SDV findings in a clear, structured, and GCP-compliant format.

What Is SDV Documentation in Monitoring Reports?

SDV documentation refers to the section within the MVR where the CRA describes the extent of SDV performed during a site visit, the findings, any discrepancies noted, resolution status, and comments on overall data quality. It serves as a traceable record for sponsors, QA teams, and regulatory auditors.

Where Should SDV Appear in the Monitoring Visit Report?

Most MVR templates include dedicated sections or subheadings such as:

• Source Data Verification (SDV)
• Data Quality and Integrity
• CRF vs Source Review
• Query Resolution and Data Entry Timeliness

What to Include in SDV Documentation

1. Scope and Subjects Covered

Start with a summary of which subjects and visits were verified:

• “SDV was performed for Subjects 001, 003, and 005 (Visit 2 and 3).”
• “Focus was placed on screening, informed consent, AE reporting, and dosing records.”

2. Percentage or Level of SDV Completed

• “100% SDV was completed for critical fields as outlined in the SDV Plan.”
• “Approximately 50% random SDV was performed for non-critical labs and demographic data.”

3. Summary of Observations

Note the quality and consistency of the data:

• “No major discrepancies were noted between the source documents and CRF entries.”
• “One discrepancy found in Subject 003’s dosing date was immediately queried and corrected.”

4. Query and Discrepancy Management

• “Two data queries were raised for Subject 005 regarding AE term spelling and missing lab date.”
• “Site acknowledged both queries during the visit and agreed to correct within 24 hours.”

5. Overall SDV Assessment

This narrative should be evaluative:

• “The site maintains high-quality source documentation and entered CRF data in a timely manner.”
• “No concerns were identified regarding GCP or protocol compliance in the reviewed subjects.”

Using SDV Checklists and Logs

To maintain audit trails and ensure consistency, CRAs should also complete SDV checklists/logs. These should be referenced in the MVR:

• “See attached SDV checklist in trip report appendix.”
• “Discrepancies noted were logged in the site SDV tracker maintained in the CTMS.”

Tips for Consistent SDV Documentation

1. Follow your organization’s Pharma SOP documentation standards
2. Use structured language for clarity and traceability
3. Be objective—do not make assumptions or speculative comments
4. Document even when no issues were found (“No discrepancies noted”)

CRA Example Entry

Example:

“SDV was performed for 3 subjects across screening and follow-up visits. Critical fields such as informed consent, eligibility criteria, AE/SAE, and IP administration were verified against source documents. One minor data discrepancy (date of AE onset) was noted, queried, and resolved on-site. Overall, the data was accurate, timely, and well-documented.”

Incorporating CTMS and EDC Tools

CRAs should leverage CTMS systems to document which pages and fields were verified and auto-sync with monitoring reports where possible. Some systems allow flagging SDV completion status per subject, which enhances oversight by the sponsor and QA teams. For more on monitoring documentation, refer to Stability Studies.

Aligning with Regulatory Guidelines

Agencies like the EMA expect sponsors to maintain documented proof of SDV scope and execution. Inadequate SDV records have led to observations during site inspections. Use SDV documentation as part of your inspection readiness package.

Conclusion

Accurate and detailed SDV documentation is vital for clinical trial success. It serves as evidence of compliance, facilitates effective communication with sponsors, and prepares sites for regulatory audits. CRAs should treat MVR entries related to SDV not just as formality but as critical records that uphold trial integrity and transparency.